Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retreatment”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Testing effectiveness (Phase 2)Study completedNCT00433069
What this trial is testing

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Who this might be right for
Chronic Hepatitis C
University Hospital, Geneva 5
Not applicableUnknownNCT05147025
What this trial is testing

Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization

Who this might be right for
Revascularization
Minia University 60
Testing effectiveness (Phase 2)Ended earlyNCT00206661
What this trial is testing

Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06913673
What this trial is testing

Postoperative Pain and Incidence of Extrusion Following the Use of Two Intra-canal Medications in Retreatment of Single Rooted Teeth

Who this might be right for
Endodontic Disease
Minia University 30
Not applicableNot Yet RecruitingNCT07566286
What this trial is testing

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Who this might be right for
Chin Augmentation
Galderma R&D 100
Large-scale testing (Phase 3)Study completedNCT05254457
What this trial is testing

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Who this might be right for
Plantar Fibromatosis
Endo USA Inc., a Keenova Therapeutics Company 145
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Not applicableStudy completedNCT05091554
What this trial is testing

Intraoral Cryotherapy in Root Canal Retreatment

Who this might be right for
Cryotherapy Effect
Izmir Katip Celebi University 118
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Testing effectiveness (Phase 2)WithdrawnNCT03841565
What this trial is testing

Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Academic and Community Cancer Research United
Post-approval studies (Phase 4)Study completedNCT00405301
What this trial is testing

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Who this might be right for
Drug Induced HepatotoxicityTuberculosis
All India Institute of Medical Sciences 175
Large-scale testing (Phase 3)UnknownNCT04679064
What this trial is testing

Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment

Who this might be right for
Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 427
Not applicableStudy completedNCT01126476
What this trial is testing

Proton Radiotherapy for Recurrent Tumors

Who this might be right for
Tumors
Abramson Cancer Center at Penn Medicine 24
Large-scale testing (Phase 3)Study completedNCT02207244
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 992
Post-approval studies (Phase 4)Study completedNCT01498640
What this trial is testing

Retreatment of Recurrent Dupuytren's Contractures

Who this might be right for
Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 52
Not applicableStudy completedNCT03750162
What this trial is testing

Bacteria Elimination in Retreatment Cases Using Different Disinfection Techniques

Who this might be right for
Root Canal InfectionPeriapical; Infection
Bulent Ecevit University 36
Large-scale testing (Phase 3)Ended earlyNCT00381810
What this trial is testing

Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Genentech, Inc. 31
Large-scale testing (Phase 3)Study completedNCT02300220
What this trial is testing

Targeted Retreatment of COPD Exacerbations

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Imperial College London 144
Not applicableLooking for participantsNCT07453576
What this trial is testing

Effect Of Different Sodium Hypochlorite Concentrations On Intracanal Substance P, CGRP And Opiorphin Levels And Postoperative Pain During Root Canal Retreatment

Who this might be right for
Persistent Apical Periodontitis
KEZBAN MELTEM ÇOLAK 60
Testing effectiveness (Phase 2)Ended earlyNCT02091752
What this trial is testing

A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)

Who this might be right for
Primary Myelofibrosis
Novartis Pharmaceuticals 3
Load More Results